Pfizer’s COVID sales to top $50bn this year, investors want more

CEO Albert Bourla says final sales for COVID-19 antiviral Paxlovid could be "way bigger" than forecasts.

Sawabiya YarKarkara Sawabiya YarKarkara
Feb 9, 2022 - 08:47
0 5
Pfizer’s COVID sales to top $50bn this year, investors want more
CEO Albert Bourla says final sales for COVID-19 antiviral Paxlovid could be "way bigger" than forecasts.
Read More